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Abstract 
Most individuals at ultra-high risk (UHR) for psychosis do not transition to frank illness. 
Nevertheless, many have poor clinical outcomes and impaired psychosocial functioning. This 
study used voxel-based morphometry to investigate if baseline grey and white matter brain 
densities at identification as UHR were associated with functional outcome at medium- to 
long-term follow-up. Participants were help-seeking UHR individuals (n=109, 54M:55F) 
who underwent magnetic resonance imaging at baseline; functional outcome was assessed an 
average of 9.2 years later. Primary analysis showed that lower baseline grey matter density, 
but not white matter density, in bilateral frontal and limbic areas, and left cerebellar declive 
were associated with poorer functional outcome (SOFAS). These findings were independent 
of transition to psychosis or persistence of the at-risk mental state. Similar regions were 
significantly associated with lower self-reported levels of social functioning and increased 
negative symptoms at follow-up. Exploratory analyses showed that lower baseline grey 
matter densities in middle and inferior frontal gyri were significantly associated with decline 
in GAF score over follow-up. There was no association between baseline grey matter density 
and IQ or positive symptoms at follow-up. The current findings provide novel evidence that 
those with the poorest functional outcomes have the lowest grey matter densities at 
identification as UHR, regardless of transition status or persistence of the at-risk mental state. 
Replication and validation of these findings may allow for early identification of poor 
functional outcome and targeted interventions. 
 
Keywords:  grey matter density; functional outcome; psychosis; ultra-high risk; voxel-
based morphometry; negative symptoms; clinical high risk 
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Introduction 
For many years, transition to frank psychotic illness has been the outcome measure of 
interest in research investigating people at ultra-high risk (UHR) for psychosis
1
. It is now 
thought that the structural brain alterations seen in schizophrenia and other psychoses (such 
as increases in ventricular volume and decreases in grey and white matter volume
2-4
) may 
arise during or even before the onset phase of psychosis
5-8
. These brain changes have a 
demonstrated relationship with transition to psychosis
5, 9-12
 and may serve as biomarkers for 
onset of illness
13
 and inform intervention efforts
14
. 
However, the majority of UHR individuals do not transition to psychosis
15
 and despite 
this, many still show poor psychosocial functioning at follow-up
16-19
. Cornblatt et al.
20
 
explain this using a model consisting of two dimensions. The first dimension represents a 
period of vulnerability caused by early insult that impacts brain pathology. This vulnerability 
is manifested in psychosocial problems such as Cognitive deficits, Affective disturbances, 
Social Isolation, and School failure that are together referred to in abbreviated form as the 
CASIS model. Presence of basic symptoms
21, 22
 could be associated with this dimension, 
which may underlie poor functioning and is necessary, but not sufficient, for the development 
of schizophrenia. The second dimension is characterised by an underlying vulnerability for 
positive psychotic symptomatology. These symptoms may develop in only a subset of 
individuals with CASIS vulnerability
20
 who eventually develop psychosis. Measuring 
psychosocial outcome, particularly in the early stages of psychosis, is thus important not only 
for our understanding of psychotic illnesses and their causes
19, 23-25
 but also for our 
understanding of those who are in the first dimension and show poor functioning, but never 
transition to frank psychotic illness. Furthermore, functional impairment may be related to the 
presence or development of non-psychotic disorders that are common in UHR individuals
26
. 
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Research in UHR individuals
16, 27, 28
 has shown that reduced neurocognitive 
performance on measures of verbal learning and memory, processing speed and attention, and 
verbal fluency predicts poor functional outcome. Functional outcomes also appear to be 
associated with a history of childhood maltreatment, regardless of transition status
29
, and non-
resolving attenuated psychotic symptoms
30, 31
. The limited research on associated brain 
functioning shows that poorer social functioning as measured by the Social Attainment 
Survey
32
 can be predicted by increased activation in anterior cingulate and left inferior frontal 
gyrus during performance of a reasoning language processing task
33
. Likewise, poor 
functioning as indicated by low Global Assessment of Functioning (GAF
34
) scores has been 
predicted by increased left inferior frontal and insula activation during performance of a 
verbal fluency task and lower thalamic glutamate levels
35
. On the structural level, lower 
baseline fractional anisotropy (FA) in the hippocampus and inferior longitudinal fasciculus in 
UHR individuals has been shown to predict deterioration in social and role functioning at 15 
month follow-up
36
. These latter studies have been limited by the small UHR samples and 
short follow-up period (6-24 months) for assessment of functional outcome.  
The current study aimed to further investigate the structural alterations associated 
with poor functional outcome in a larger sample of UHR individuals followed over the 
medium- to long-term. We adopted a voxel-based morphometry approach to investigate 
whether grey and white matter brain density of individuals at UHR for psychosis could 
predict functional outcome 2.4 to 12.9 years later, and if this association would be related to 
transition status. Based on the findings described above, we predicted that lower densities in 
frontal and temporal regions at baseline would be associated with poorer psychosocial 
functioning at follow-up.  
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Methods 
Participants 
UHR individuals were recruited from the Personal Assessment and Crisis Evaluation 
(PACE) Clinic at Orygen Youth Health (now Orygen, The National Centre of Excellence in 
Youth Mental Health), in Melbourne, Australia. They were part of a cohort of UHR patients 
recruited to participate in research studies between 1993 and 2006. Current data are from 
participants with both baseline MRI and follow-up functional outcome data (n=109, 
54M:55F). Inclusion criteria were based on the UHR entry criteria for PACE which are the 
presence of attenuated psychotic symptoms, brief limited intermittent psychotic symptoms 
(BLIPS), and/or trait vulnerability for psychotic illness (presence of schizotypal personality 
disorder or a first-degree family history of psychosis), as well as deterioration in functioning 
or persistent low functioning. Up to 1999, these criteria were established using the Brief 
Psychiatric Rating Scale (BPRS
37
)/Comprehensive Assessment of Symptoms and History 
(CASH
38
)/GAF
34
 and the Comprehensive Assessment of At-Risk Mental States 
(CAARMS
39
). From 1999, the CAARMS replaced the BPRS/CASH as the means of 
establishing UHR status. Participants were aged between 15-30 years old and had no history 
of psychotic illness, organic cause for presentation or past neuroleptic exposure equivalent to 
a total continuous haloperidol dose of more than 15 mg (i.e. neuroleptics being taken day 
after day until the 15mg haloperidol equivalent had been reached). Exclusion from imaging 
studies were neurological disorder, history of significant head injury, seizures or 
contraindication for magnetic resonance imaging (MRI). All participants provided written 
informed consent and the study was approved by the local Research and Ethics Committee 
(Melbourne Health). 
Participants were followed up using the tracking system described in Lin et al.
40
 More 
details regarding this long-term follow-up study can be found in Nelson et al.
15
 Follow-up 
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assessments of this sample took place between 2.4 and 12.9 (mean=9.2, SD=2.5, median=9.8) 
years after study entry at PACE. 
 
Assessments 
Participants underwent clinical assessment and MRI at baseline. Clinical assessment 
included assessment of positive symptoms using the BPRS
37
, negative symptoms using the 
Scale for the Assessment of Negative Symptoms (SANS
41
), and GAF
34
 for functioning. 
During the follow-up assessment, baseline measures were re-administered and the Social and 
Occupational Functioning Assessment Scale (SOFAS
42
) and Quality of Life Scale (QLS
43
) 
were used as indices of functional outcome. For participants recruited before the year 2000 
(n=73, 67% of the current sample), IQ at follow-up was measured using subtests of the 
Wechsler Adult Intelligence Scale-Revised (WAIS-R
44
) proposed by Ward
45
. These subtests 
are information, picture completion, block design, arithmetic, digit span, similarities and digit 
symbol. For participants recruited from the year 2000 onwards (n=36, 33% of the current 
sample), the full Wechsler Abbreviated Scale of Intelligence (WASI
46
) was used to measure 
IQ at follow-up. Transition to frank psychosis was established using the CAARMS
39
 or the 
state public mental health records when CAARMS data were not available. 
 
MRI acquisition 
80% (n=87) of the T1-weighted MRI scans were obtained using a 1.5T GE Signa MR 
scanner: 124 slices of 1.5mm thickness, TR=1.43s, TE=3.3ms, flip angle 30º, matrix 
256x256, FOV 24cm. The remaining 20% (n=22) of the T1-weighted MRI scans were 
obtained using a 3T GE LX Horizon Scanner: 124 slices of 2mm thickness, TR=3.6s, 
TE=9ms, flip angle 30º, matrix 410x410, FOV 20cm.  
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Data analysis 
Behavioural data were analysed using IBM SPSS Statistics 21 for Windows (IBM 
Corp., Armonk, NY). T1-weighted MRI images were automatically processed using the 
optimised voxel-based morphometry (VBM8) toolbox (http://dbm.neuro.uni-jena.de/vbm/) in 
statistical parametric mapping software (SPM8, Friston, The Wellcome Trust Centre for 
Neuroimaging, London, UK; http://www.fil.ion.ucl.ac.uk/spm). For details on the 
preprocessing of the data see supplementary materials. Regionally specific differences in the 
association of baseline grey and white matter density (both lower and higher) with functional 
outcome were assessed using multiple regressions with gender, age, field strength of the 
scanner, length of the follow-up period and transition status specified as nuisance variables. 
Threshold-free cluster enhancement (TFCE) is a spatially sensitive statistical inference 
algorithm that is based on the sensitivity benefits of cluster-based inference but is not 
dependent on an arbitrary cluster-forming threshold
47
. This algorithm was applied to optimise 
activation in areas that show spatial contiguity and results were considered significant at 
p<0.05 Family-Wise Error (FWE) corrected.  
SOFAS scores were used to investigate the association of baseline grey and white 
matter densities with psychosocial functioning at follow-up. The strength of the SOFAS is 
that, in contrast with the GAF, its scores are independent of the overall severity of the 
individual’s psychological symptoms and are based on the clinician’s judgment of the overall 
level of functioning. Whilst we argue superiority of the SOFAS over the GAF for use in this 
study, the GAF is commonly used and data were available for 108 participants at both 
baseline and follow-up for this measure (in contrast with SOFAS scores which were only 
available at follow-up). The association between baseline grey matter density and baseline 
GAF score and change in GAF score over time was therefore also investigated. Change in 
GAF score was calculated for each participant relative to their baseline score and constituted 
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of a percentage change score and an absolute change score. The SOFAS does not assess 
social and role functioning separately and therefore the QLS was additionally employed. The 
QLS is based on self-report but has the advantage that its items can be factored into social 
functioning, vocational functioning and engagement
48
. Data on this measure was available for 
108 participants and scores on the social and vocational functioning scales were used to 
investigate if density associations were more specifically associated with either social- or 
vocational functioning.   
Given that negative symptoms and general cognitive ability are strongly associated 
with functional outcome
23, 27
, density associations with negative symptoms and IQ measured 
at follow-up were additionally examined, along with density associations with positive 
symptoms at follow-up. Available follow-up data were as follows; SANS n=107, IQ n=102, 
and BPRS positive n=105. 
 
Results 
 Characteristics of the sample are presented in Table 1. Of the 109 participants, 38 
(35%) had transitioned to psychosis by the time of follow-up. The average length of time to 
conversion was 622 days (SD=719 days). Of those who had not transitioned to psychosis by 
the time of follow-up, 27 (38%) met APS or BLIPS criteria. Further details about the sample 
are presented in the supplementary materials.  
 
-Table 1- 
 
Primary analysis 
Lower than average baseline grey matter density was significantly associated with 
lower SOFAS scores at follow-up. This association was found in large clusters in medial 
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prefrontal cortex, right cingulate gyrus extending into anterior cingulate, left anterior 
cingulate extending into anterior frontal cortex and subcallosal gyrus, and left cerebellar 
declive (Table 2, Figure 1). These areas of association were lower in size when symptom 
severity (SANS and BPRS psychotic subscale scores at baseline) were additionally added as 
nuisance variables (supplementary materials Table A2). To determine whether this pattern 
was being driven by the individuals who had transitioned to psychosis at follow-up (note, 
transition status at follow-up was entered as a nuisance variable in all analyses), a secondary 
analysis was conducted. A comparison of the relationship of baseline grey matter with 
functional outcome in the identified bilateral frontal and limbic areas, and left declive, in 
those who had transitioned to psychosis at follow-up (n=37) with those who had not (n=69) 
revealed no significant differences. The same comparison for those who had not transitioned 
to psychosis but met APS or BLIPS criteria at follow-up (n=27) with those who had not 
transitioned to psychosis and did not meet APS or BLIPS criteria at follow-up (n=42) 
revealed no significant differences either.  There was no significant association between 
higher baseline grey matter density and lower SOFAS scores at follow-up. There was no 
significant association between baseline white matter density (lower or higher) and SOFAS 
scores at follow-up and therefore subsequent analyses focussed on grey matter density 
associations only.  
 
-Table 2, Figure 1- 
 
Exploratory analyses 
 No significant association was found between baseline grey matter density (lower or 
higher) and baseline GAF score or percentage change in GAF score. Lower baseline grey 
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matter density in middle and inferior frontal gyri was, however, significantly associated with 
decline in GAF score over follow-up (supplementary materials Table A3, Figure A1). 
Lower baseline grey matter density in left medial prefrontal cortex was significantly 
associated with lower social functioning scores on the QLS at follow-up (Table 2, Figure 1). 
There was no significant association between higher baseline grey matter density and social 
functioning scores on the QLS at follow-up. No significant association was observed between 
baseline grey matter density (lower or higher) and vocational functioning scores on the QLS 
at follow-up. 
Significantly lower baseline grey matter density was observed in a large cluster 
extending from medial prefrontal cortex into cingulate gyrus and anterior cingulate, and 
clusters in right precentral and cingulate gyrus, left orbitofrontal cortex extending into 
anterior cingulate, and left anterior cingulate extending into caudate in association with 
higher SANS scores at follow-up (Table 3, Figure 2). Further exploratory analyses revealed 
that this association was not driven by a particular SANS subscale. There was no significant 
association between higher baseline grey matter density and SANS scores at follow-up.  
No significant association was observed between baseline grey matter density and IQ 
at follow-up or between baseline grey matter density and positive symptoms at follow-up. 
 
-Table 3, Figure 2- 
 
Discussion 
 This study investigated the association between baseline grey and white matter 
density and functional outcome 2.4 to 12.9 years after identification as UHR for psychosis. 
Lower baseline grey matter density in large clusters in bilateral frontal and limbic regions and 
left cerebellar declive were associated with poorer functional outcome. These findings were 
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independent of transition status or persistence of the at-risk mental state at follow-up 
(although in this regard we were only powered to detect a large effect and replication in 
larger samples is required). We did not observe an association between larger baseline grey 
matter density and poorer functional outcome, and there was no association between baseline 
white matter density (lower or higher) and functional outcome. Lower baseline grey matter 
density in middle and inferior frontal gyri was associated with absolute decline in 
functioning. When social and vocational functioning were investigated separately, poorer 
social functioning at follow-up was associated with lower baseline grey matter density in an 
area of left medial prefrontal cortex that overlapped with the medial prefrontal region 
observed for the association with functional outcome. Even though both social and vocational 
functional scores on the QLS showed a strong relationship with functioning as measured by 
the SOFAS, vocational functioning at follow-up was not associated with baseline grey matter 
density. Exploration of the association between baseline grey matter density and increased 
negative symptoms at follow-up revealed areas of lower density in bilateral frontal and limbic 
regions that partially overlapped with those observed in the association with functional 
outcome. No association was found between baseline grey matter density and IQ or positive 
symptoms at follow-up. 
The findings regarding QLS social functioning do advocate for a key role for social 
dysfunction in the poor functional outcomes in this sample. Both the anterior and medial 
prefrontal regions have been shown to play an important role in emotion processing
49
, and in 
social abilities such as self-referential processing
50, 51
, empathy, Theory of Mind and 
perspective taking
52-54
. The brain areas observed in the association of baseline grey matter 
density and SOFAS scores at follow-up support this suggestion as recruitment of the anterior 
cingulate has been associated with performance of emotional tasks with cognitive demand 
and emotional recall/imagery
49
. Lower baseline grey matter density of the declive was 
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associated with poorer functional outcome but not with increased negative symptoms at 
follow-up, providing additional support for the suggestion that social dysfunction may 
underlie poorer functional outcome in the current sample. The cerebellum has been 
implicated in social-cognitive functioning in that it provides domain-general executive and 
semantic support
55
, consistent with findings of higher cerebellar activity when executive 
resources are demanded to support mentalizing in contexts with a high level of abstraction
55
. 
It needs noting that the current SOFAS findings represent an overall association between 
lower baseline grey matter density and poorer psychosocial outcome that includes social and 
role functioning. While many of the observed areas respond to social cognitive paradigms, 
they may also have involvement in so called ‘cold cognition’ paradigms in which rational 
reasoning takes prominence over emotions 
56, 57
.  
The observed partial overlap in brain areas that showed lower grey matter density at 
baseline in association with poorer functional outcome and increased negative symptoms 
illustrates the strong association between negative symptoms and functional outcome on both 
the conceptual and neural level and is consistent with the manifestation of cognitive deficits, 
affective disturbances, social isolation and school failure as suggested by the first dimension 
of vulnerability of the CASIS model
20
.  
The brain areas that show lower grey matter density  in association with poorer 
functional outcome as assessed by the SOFAS do not include the dorsolateral prefrontal 
cortex, suggesting that changes in baseline density of this brain area and associated cognitive 
impairments are not associated with poorer functioning in later years. This is consistent with 
our failure to observe an association between baseline grey matter density and estimated IQ at 
follow-up as an approximate measure of general cognitive ability. This is also in line with our 
earlier finding
16
 which showed that specific neurocognitive domains (verbal learning and 
memory, processing speed and attention, and verbal fluency), but not global cognitive 
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impairment, predicted poor functional outcome. In contrast, the area observed in association 
with decline in GAF score in the period between baseline and follow-up does overlap with 
the dorsolateral prefrontal cortex. Lower densities observed in this association may, however, 
reflect worse symptomatic outcome rather than cognitive impairment (for further discussion 
see our recent paper on attenuated psychotic symptoms in this sample
30
) or general low 
functioning at follow-up. 
The current findings support recent statements that treatment should not only be 
focussed on those who will develop above threshold psychotic symptoms but also on those 
with poor functional outcome
23, 25, 58
. Moreover and consistent with the current findings, 
treatments that specifically target social impairments, such as social cognitive remediation
59, 
60
, could be a way of alleviating long-term social disability and distress. Lower grey matter 
densities as observed in the current study are commonly found in first-episode psychosis
6, 7, 61
 
and chronic schizophrenia
2, 62
. Detection of these structural alterations as early as the at-risk 
mental state supports early intervention approaches in those with a prospective diagnosis of 
psychosis but also in those with a prospective diagnosis of non-psychotic disorders that are 
associated with poor functional outcome. Evidence is emerging that interventions involving 
exercise or the administration of essential fatty acids alter brain structure
63-67
 and a recent 
meta-analysis has shown that these efforts, as well as administration of neuroleptics and 
cognitive behavioural therapy, may show efficacy in preventing or delaying transition
68
. 
Cognitive enhancement therapy in patients with schizophrenia or schizoaffective disorder has 
been shown to not only improve neurocognitive functioning
69
, but to also have 
neuroprotective properties as demonstrated by preservation and even increase of grey matter 
density in limbic areas
70
. Early intervention using these techniques may preserve function
21
. 
The next step should therefore involve implementation and evaluation of the efficacy of 
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psychosocial interventions in individuals at UHR for psychosis to reverse the structural 
alterations that may lead to poorer psychosocial functioning.  
A limitation of the current study is the long recruitment period spanning the years 
1993-2006. During this period, changes in recruitment, treatment and operationalisation of 
the UHR criteria took place at the PACE clinic. As these changes did not fully account for the 
decline in transition rates that has been observed over the years, and other factors may have 
had additional impact
71
, they were not controlled for in the current study. A further limitation 
is the time to follow-up; this varied widely from 2.4 to 12.9 years after baseline assessment 
and may have had an impact on functional outcome. Participants scanned at the 3T scanner 
were recruited later, resulting in a shorter follow-up period for this sample than data acquired 
on the 1.5T scanner. To control for this, length of the follow-up period and field strength of 
scanner were specified as nuisance variables in all analyses. However, as there are likely to 
be a number of sample differences over the recruitment periods
71
, including over the period 
where data were obtained at 1.5T, this makes any direct comparison between 1.5T and 3T 
data far less informative. Finally, only limited information was available regarding 
participants’ treatment at baseline and during the period between baseline and follow-up 
making it difficult to control for the potential impact of this factor in our analyses. Future 
research would do well to record these factors in more detail and control for them in 
subsequent analyses. 
Taken together, the current findings provide novel evidence that those with the 
poorest functional outcomes have the lowest grey matter densities at identification as UHR, 
regardless of transition status or persistence of the at-risk mental state. These findings 
increase our understanding of psychotic illnesses and their causes and once replicated and 
validated may increase our ability to predict which UHR individuals are at greatest risk of 
having the poorest functional outcome. This may enable us to target interventions for this 
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group accordingly. Moreover, the current findings provide scope for application in the wider 
context of mental health, by increasing our understanding of those who show poor 
functioning but never transition to frank psychotic illness, and may suggest a shift of focus to 
functioning rather than distinct diagnostic categories.   
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Table 1  
Sample characteristics  
 
Measure Baseline Follow-up Baseline vs follow-
up 
 n Mean SD n Mean SD p value 
Age 109 19.5 3.6 109 28.7 4.7 <0.001 
IQ    102 99.9 19.4  
BPRS psychotic subscale 107 8.9 2.9 108 6.9 3.7 <0.001 
SANS total 108 18.7 12.6 108 11.4 13.9 <0.001 
SOFAS    109 67.2 15.8  
GAF 108 59.5 12.3 109 64.1 15.3 <0.006 
QLS social functioning    108 36.6 10.6  
QLS vocational functioning    108 22.7 8.5  
Intake criteria n %      
APS only 53 48.6      
BLIPS only 10 9.2      
Vulnerability only 19 17.4      
APS + BLIPS 6 5.5      
APS + vulnerability 17 15.6      
BLIPS + vulnerability 1 0.9      
APS + BLIPS + 
vulnerability 
3 2.8      
 
 
Note. BPRS, Brief Psychiatric Rating Scale; SANS, Scale for the Assessment of Negative 
Symptoms; SOFAS, Social and Occupational Functioning Assessment Scale; GAF, Global 
Assessment of Functioning; QLS, Quality of Life Scale; APS, attenuated psychotic 
symptoms; BLIPS, brief limited intermittent psychotic symptoms; SD, standard deviation. 
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Table 2  
Association between lower baseline grey matter density and poor functional outcome 
(SOFAS, QLS) 
 
Region BA Left/right Cluster size MNI coordinates p-value 
    x y z  
Association with SOFAS scores  
Medial prefrontal cortex 10 L 1952
a
 -9 51 16 0.017 
Medial prefrontal cortex 10   0 50 16 0.018 
Medial prefrontal cortex 9   0 44 25 0.018 
Cingulate gyrus 32 R 1352
b
 14 14 28 0.021 
Anterior cingulate 32 R  16 24 25 0.021 
Anterior cingulate 33 R  4 8 25 0.030 
Anterior cingulate 32 L 945
c
 -12 36 9 0.028 
Anterior frontal cortex 10 L  -12 34 -6 0.031 
Subcallosal gyrus 25 L  -9 22 -11 0.034 
Declive  L 142 -57 -58 -23 0.033 
Association with QLS social functioning scores  
Medial prefrontal cortex 10 L 229 -4 51 16 0.033 
Medial prefrontal cortex 9 L  -2 45 24 0.044 
 
Note. The coordinates represent the loci of the local maxima within each distinct anatomical 
region in Montréal Neurological Institute (MNI) space. All clusters are FWE corrected for 
multiple comparisons using TFCE. Cluster sizes are indicated in number of voxels. BA, 
Brodmann Area. 
a
 This cluster extended further into BA 47, 32 and 6. 
b
 This cluster extended 
further into BA 24. 
c
 This cluster extended further into BA 9, 24 and the caudate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 27 of 38
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Reniers et al. - NEUROANATOMICAL PREDICTORS OF FUNCTIONAL OUTCOME 28 
 
Table 3  
Association between lower baseline grey matter density and increased negative symptoms 
(SANS) at follow-up 
 
Region BA Left/right Cluster size MNI coordinates p-value 
    x y z  
Medial prefrontal cortex 9  3353
a
 0 45 24 0.010 
Cingulate gyrus 32 R  15 15 30 0.012 
Anterior cingulate 32 R  16 24 25 0.012 
Precentral gyrus 6 R 100 51 -3 40 0.043 
Orbitofrontal cortex 11 L 40 -9 27 -9 0.048 
Anterior cingulate 32 L  -10 34 -6 0.048 
Anterior cingulate 25 L 38 -4 14 -11 0.049 
Caudate  L  -3 9 -3 0.049 
Cingulate gyrus 23 R 3 10 -16 33 0.050 
 
Note. The coordinates represent the loci of the local maxima within each distinct anatomical 
region in MNI space. All clusters are FWE corrected for multiple comparisons using TFCE. 
Cluster sizes are indicated in number of voxels. BA, Brodmann Area. 
a
 This cluster extended 
further into BA 6 and 8. 
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Figure Legends 
 
Figure 1. Association between lower baseline grey matter density and poor functional 
outcome.  
TFCE-enhanced images displaying areas of lower baseline grey matter density associated 
with poor functional outcome as indicated by lower scores on the Social and Occupational 
Functioning Assessment Scale (SOFAS) (a, b, c) and social functioning subscale of the 
Quality of Life Scale (QLS) (d) at follow-up. Threshold at p<0.05 FWE corrected. Crosshairs 
at a) medial prefrontal cortex [-9 51 16], b) cingulate gyrus [14 14 28], c) anterior cingulate [-
12 36 9], d) medial prefrontal cortex [-4 51 16]. Colour bars show TFCE-enhanced t-statistic. 
 
Figure 2. Association between lower baseline grey matter density and increased negative 
symptoms at follow-up.  
TFCE-enhanced images displaying areas of lower baseline grey matter density associated 
with increased negative symptoms as indicated by higher scores on the Scale for the 
Assessment of Negative Symptoms (SANS) at follow-up. Threshold at p<0.05 FWE 
corrected. Crosshairs at a) medial prefrontal cortex [0 45 24], b) cingulate gyrus [15 15 30], 
c) anterior cingulate [16 24 25]. Colour bar shows TFCE-enhanced t-statistic. 
 
 
 
 
 
 
 
 
Page 29 of 38
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
 
 
 
145x183mm (96 x 96 DPI)  
 
 
Page 30 of 38
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
 
 
 
148x122mm (96 x 96 DPI)  
 
 
Page 31 of 38
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Supplementary material 
Data analysis - preprocessing 
Images processed using VBM8 were written out to 1.5x1.5x1.5mm isotropic voxels in 
standard anatomical space (Montreal Neurological Institute, 
http://www.bic.mni.mcgill.ca/brainweb) and segmented into grey matter, white matter and 
cerebrospinal fluid. Data quality and homogeneity of the images were checked. Data of three 
participants were excluded from further analyses due to the mean covariance between the 
volumes being more than two standard deviations from the mean of the group. The 
modulated normalised images were smoothed with an 8mm Full-Width at Half-Maximum 
Gaussian kernel. Employing the General Linear Model, statistical analysis was performed on 
a voxel-by-voxel basis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 32 of 38
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Sample characteristics 
GAF scores at baseline did not correlate with SOFAS or QLS scores at follow-up but 
did show a weak positive correlation with GAF scores at follow-up (r=0.19, p<0.05, d=0.33). 
SOFAS scores at follow-up showed a weak negative correlation with SANS scores at 
baseline (r=-0.24, p<0.05, d=3.39) but no significant correlation was found with baseline 
GAF or BPRS psychotic subscale scores. SOFAS scores at follow-up furthermore showed a 
strong positive correlation with follow-up scores of GAF (r=0.94, p<0.001, d=5.36), QLS 
social functioning (r=0.76, p<0.001, d=2.35), and QLS vocational functioning (r=0.74, 
p<0.001, d=2.20). SANS scores at baseline correlated significantly with GAF scores at 
baseline (r=-0.49, p<0.001, d=3.29), and furthermore GAF (r=-0.27, p<0.01, d=3.24) and 
QLS vocational functioning (r=-0.22, p<0.05, d=0.37) at follow-up. There was no association 
with QLS social functioning or IQ at follow-up. SANS scores at follow-up correlated 
significantly with SOFAS (r=-0.71, p<0.001, d=3.75), GAF (r=-0.69, p<0.001, d=3.61), QLS 
social functioning (r=-0.71, p<0.001, d=2.03), QLS vocational functioning (r=-0.58, p<0.001, 
d=0.98), and IQ (r=-0.22, p<0.05, d=5.24) at follow-up. IQ at follow-up (available for n=102) 
showed a weak positive correlation with SOFAS scores at follow-up (r=0.24, p<0.05, d=0.50) 
and GAF scores at follow-up (r=0.27, p<0.01, d=0.57) but was not significantly related to 
QLS scores.  
Of the 38 participants who transitioned to psychosis by the time of follow-up, 14 had 
a diagnosis of schizophrenia, 5 bipolar disorder with psychotic features, 1 schizoaffective 
disorder, 5 psychotic disorder NOS, 5 MDD with psychotic features, 3 delusional disorder, 2 
substance induced psychotic disorder, 2 brief psychotic disorder and for 1 participant the 
specific diagnosis was not available. Those with a diagnosis of schizophrenia (n=14) did not 
have a significant worse outcome than those with a differential diagnosis. Neuroleptic and 
antidepressant medication use at baseline was documented for 70 (64%) of the 109 
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participants. Of these participants, 1 (1%) reported taking neuroleptics and 11 (16%) reported 
antidepressant use while the remainder (n=58, 83%) reported no use of neuroleptics or 
antidepressants. At follow-up, 29 participants (27%) reported taking medication for 
psychiatric problems for some of the period between baseline and follow-up while 22 
participants (20%) reported to have been on medication most of the time. 23 (21%) 
participants received low-dose neuroleptics (risperidone) and 1 (1%) received low-dose 
lithium as trial treatment at PACE after study entry. 55 participants (50%) reported receiving 
non-pharmacological treatment. Overall, 79 participants (72%) received either (n=36) or both 
(n=43) forms of treatment in the period between baseline and follow-up. Those who received 
neuroleptic medication in the period between baseline and follow-up scored significantly 
lower on all functioning measures at both baseline and follow-up than those who did not 
receive any neuroleptic medication (Table A1).  
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Table A1  
Functioning scores for those who received neuroleptic medication in the period between 
baseline and follow-up and those who did not receive any neuroleptic medication during this 
time 
 
Measure Neuroleptics since 
entry at PACE 
No neuroleptics since 
entry at PACE 
Neuroleptics vs no 
neuroleptics 
 n Mean SD n Mean SD p value 
 Baseline     
GAF 24 54.0 10.7 74 61.4 11.7 <0.008 
 Follow-up     
SOFAS 24 56.2 17.1 75 71.2 13.8 <0.001 
GAF 24 53.5 16.0 75 67.8 13.8 <0.001 
QLS social 
functioning 
23 31.3 13.4 75 38.1 9.3 <0.05 
QLS vocational 
functioning 
23 17.9 9.9 75 24.6 7.2 <0.006 
 
Note. GAF, Global Assessment of Functioning; SOFAS, Social and Occupational 
Functioning Assessment Scale; QLS, Quality of Life Scale; SD, standard deviation. 
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Table A2  
Association between lower baseline grey matter density and poor functional outcome 
(SOFAS) including symptom severity (SANS and BPRS psychotic subscale scores) at baseline 
as nuisance variables. 
 
Region BA Left/right Cluster size MNI coordinates p-value 
    x y z  
Medial prefrontal cortex 10 L 42 -8 52 15 0.049 
Declive  L 11 -56 -60 -23 0.040 
 
Note. The coordinates represent the loci of the local maxima within each distinct anatomical 
region in MNI space. All clusters are FWE corrected for multiple comparisons using TFCE. 
Cluster sizes are indicated in number of voxels. BA, Brodmann Area; SOFAS, Social and 
Occupational Functioning Assessment Scale; SANS, Scale for the Assessment of Negative 
Symptoms; BPRS, Brief Psychiatric Rating Scale.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 36 of 38
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Table A3  
Association between lower baseline grey matter density and absolute decline in functioning 
(GAF) 
 
Region BA Left/right Cluster size MNI coordinates p-value 
    x y z  
Middle frontal gyrus 46 R 232 48 21 30 0.042 
Inferior frontal gyrus 45 R  44 16 19 0.044 
Inferior frontal gyrus 9 L 13 -45 -3 27 0.047 
 
Note. The coordinates represent the loci of the local maxima within each distinct anatomical 
region in MNI space. All clusters are FWE corrected for multiple comparisons using TFCE. 
Cluster sizes are indicated in number of voxels. BA, Brodmann Area. 
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 Figure A1. Association between lower baseline grey matter density and absolute decline in 
functioning (GAF). 
TFCE-enhanced image displaying the area of lower baseline grey matter density associated 
with functional decline as indicated by lower absolute change scores on the Global 
Assessment of Functioning scale (GAF). Threshold at p<0.05 FWE corrected. Crosshairs at 
middle frontal gyrus [48 21 30]. Colour bar shows TFCE-enhanced t-statistic. 
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